pemirolast has been researched along with Coronary Restenosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, K; Hitsumoto, T; Iizuka, T; Kaku, M; Kanai, M; Matsumoto, J; Noike, H; Ohsawa, H; Sakuragawa, H; Sakurai, T; Shimizu, K; Sugiyama, Y; Takahashi, M; Tokuhiro, K; Tomaru, T; Yoshinaga, K | 1 |
1 other study(ies) available for pemirolast and Coronary Restenosis
| Article | Year |
|---|---|
Preventive effect of an antiallergic drug, pemirolast potassium, on restenosis after stent placement: quantitative coronary angiography and intravascular ultrasound studies.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Allergic Agents; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Female; Humans; Male; Middle Aged; Pyridines; Pyrimidinones; Stents; Ultrasonography, Interventional | 2003 |